ENZO BIOCHEM, INC. Deferred Revenue
ENZO BIOCHEM, INC. had Deferred Revenue of $2.67 million as of 2021-07-31, per its 10-K filed 2022-10-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2022-10-14
- 2021-07-31: Deferred Revenue, Current $2.67M.
| Period end | Deferred Revenue, Current |
|---|---|
| 2021-07-31 | $2.67M 10-K · filed 2022-10-14 |